RIVASTIGMINA STADAFARMA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG
RIVASTIGMINA STADAFARMA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG
Commercialized
Register Number
86084
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Jul 11, 2021
Dosage Form
PARCHE TRANSDÉRMICO
Route: VÍA TRANSDÉRMICA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number86084
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
RIVASTIGMINAActive
Quantity: 6,9 mg
Name: RIVASTIGMINA
ATC CLASSIFICATION (3)
N06D
N06DA
N06DA03